Facility type and volume impact outcomes in acute myeloid leukemia—a National Cancer Database Study

Background: Outcomes of patients with newly diagnosed acute myeloid leukemia (AML) differ based on academic affiliation and case volume. The primary objective examined the impact of treatment facility type, and volume on time to treatment (TTT). Secondary objectives evaluated these same facility characteristics on overall survival (OS), receipt of chemotherapy, allogeneic hematopoietic stem cell transplant (HSCT) and/or palliative care.